Cargando…

Cardiovascular magnetic resonance characteristics and clinical outcomes of patients with ST-elevation myocardial infarction and no standard modifiable risk factors–A DANAMI-3 substudy

INTRODUCTION: A higher 30-day mortality has been observed in patients with first-presentation ST elevation myocardial infarction (STEMI) who have no standard modifiable cardiovascular risk factors (SMuRFs), i. e., diabetes, hypertension, hyperlipidemia, and current smoker. In this study, we evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazhar, Jawad, Ekström, Kathrine, Kozor, Rebecca, Grieve, Stuart M., Nepper-Christensen, Lars, Ahtarovski, Kiril A., Kelbæk, Henning, Høfsten, Dan E., Køber, Lars, Vejlstrup, Niels, Vernon, Stephen T., Engstrøm, Thomas, Lønborg, Jacob, Figtree, Gemma A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9383416/
https://www.ncbi.nlm.nih.gov/pubmed/35990971
http://dx.doi.org/10.3389/fcvm.2022.945815
_version_ 1784769396516847616
author Mazhar, Jawad
Ekström, Kathrine
Kozor, Rebecca
Grieve, Stuart M.
Nepper-Christensen, Lars
Ahtarovski, Kiril A.
Kelbæk, Henning
Høfsten, Dan E.
Køber, Lars
Vejlstrup, Niels
Vernon, Stephen T.
Engstrøm, Thomas
Lønborg, Jacob
Figtree, Gemma A.
author_facet Mazhar, Jawad
Ekström, Kathrine
Kozor, Rebecca
Grieve, Stuart M.
Nepper-Christensen, Lars
Ahtarovski, Kiril A.
Kelbæk, Henning
Høfsten, Dan E.
Køber, Lars
Vejlstrup, Niels
Vernon, Stephen T.
Engstrøm, Thomas
Lønborg, Jacob
Figtree, Gemma A.
author_sort Mazhar, Jawad
collection PubMed
description INTRODUCTION: A higher 30-day mortality has been observed in patients with first-presentation ST elevation myocardial infarction (STEMI) who have no standard modifiable cardiovascular risk factors (SMuRFs), i. e., diabetes, hypertension, hyperlipidemia, and current smoker. In this study, we evaluate the clinical outcomes and CMR imaging characteristics of patients with and without SMuRFs who presented with first-presentation STEMI. METHODS: Patients from the Third DANish Study of Acute Treatment of Patients With ST-Segment Elevation Myocardial Infarction (DANAMI-3) with first-presentation STEMI were classified into those with no SMuRFs vs. those with at least one SMuRF. RESULTS: We identified 2,046 patients; 283 (14%) SMuRFless and 1,763 (86%) had >0 SMuRF. SMuRFless patients were older (66 vs. 61 years, p < 0.001) with more males (84 vs. 74%, p < 0.001), more likely to have left anterior descending artery (LAD) as the culprit artery (50 vs. 42%, p = 0.009), and poor pre-PCI (percutaneous coronary intervention) TIMI (thrombolysis in myocardial infarction) flow ≤1 (78 vs. 64%; p < 0.001). There was no difference in all-cause mortality, non-fatal reinfarction, or hospitalization for heart failure at 30 days or at long-term follow-up. CMR imaging was performed on 726 patients. SMuRFless patients had larger acute infarct size (17 vs. 13%, p = 0.04) and a smaller myocardial salvage index (42 vs. 50%, p = 0.02). These differences were attenuated when the higher LAD predominance and/or TIMI 0-1 flow were included in the model. CONCLUSION: Despite no difference in 30-day mortality, SMuRFless patients had a larger infarct size and a smaller myocardial salvage index following first-presentation STEMI. This association was mediated by a larger proportion of LAD culprits and poor TIMI flow pre-PCI. CLINICAL TRIAL REGISTRATION: clinicaltrials.gov, unique identifier: NCT01435408 (DANAMI 3-iPOST and DANAMI 3-DEFER) and NCT01960933 (DANAMI 3-PRIMULTI).
format Online
Article
Text
id pubmed-9383416
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93834162022-08-18 Cardiovascular magnetic resonance characteristics and clinical outcomes of patients with ST-elevation myocardial infarction and no standard modifiable risk factors–A DANAMI-3 substudy Mazhar, Jawad Ekström, Kathrine Kozor, Rebecca Grieve, Stuart M. Nepper-Christensen, Lars Ahtarovski, Kiril A. Kelbæk, Henning Høfsten, Dan E. Køber, Lars Vejlstrup, Niels Vernon, Stephen T. Engstrøm, Thomas Lønborg, Jacob Figtree, Gemma A. Front Cardiovasc Med Cardiovascular Medicine INTRODUCTION: A higher 30-day mortality has been observed in patients with first-presentation ST elevation myocardial infarction (STEMI) who have no standard modifiable cardiovascular risk factors (SMuRFs), i. e., diabetes, hypertension, hyperlipidemia, and current smoker. In this study, we evaluate the clinical outcomes and CMR imaging characteristics of patients with and without SMuRFs who presented with first-presentation STEMI. METHODS: Patients from the Third DANish Study of Acute Treatment of Patients With ST-Segment Elevation Myocardial Infarction (DANAMI-3) with first-presentation STEMI were classified into those with no SMuRFs vs. those with at least one SMuRF. RESULTS: We identified 2,046 patients; 283 (14%) SMuRFless and 1,763 (86%) had >0 SMuRF. SMuRFless patients were older (66 vs. 61 years, p < 0.001) with more males (84 vs. 74%, p < 0.001), more likely to have left anterior descending artery (LAD) as the culprit artery (50 vs. 42%, p = 0.009), and poor pre-PCI (percutaneous coronary intervention) TIMI (thrombolysis in myocardial infarction) flow ≤1 (78 vs. 64%; p < 0.001). There was no difference in all-cause mortality, non-fatal reinfarction, or hospitalization for heart failure at 30 days or at long-term follow-up. CMR imaging was performed on 726 patients. SMuRFless patients had larger acute infarct size (17 vs. 13%, p = 0.04) and a smaller myocardial salvage index (42 vs. 50%, p = 0.02). These differences were attenuated when the higher LAD predominance and/or TIMI 0-1 flow were included in the model. CONCLUSION: Despite no difference in 30-day mortality, SMuRFless patients had a larger infarct size and a smaller myocardial salvage index following first-presentation STEMI. This association was mediated by a larger proportion of LAD culprits and poor TIMI flow pre-PCI. CLINICAL TRIAL REGISTRATION: clinicaltrials.gov, unique identifier: NCT01435408 (DANAMI 3-iPOST and DANAMI 3-DEFER) and NCT01960933 (DANAMI 3-PRIMULTI). Frontiers Media S.A. 2022-08-03 /pmc/articles/PMC9383416/ /pubmed/35990971 http://dx.doi.org/10.3389/fcvm.2022.945815 Text en Copyright © 2022 Mazhar, Ekström, Kozor, Grieve, Nepper-Christensen, Ahtarovski, Kelbæk, Høfsten, Køber, Vejlstrup, Vernon, Engstrøm, Lønborg and Figtree. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Mazhar, Jawad
Ekström, Kathrine
Kozor, Rebecca
Grieve, Stuart M.
Nepper-Christensen, Lars
Ahtarovski, Kiril A.
Kelbæk, Henning
Høfsten, Dan E.
Køber, Lars
Vejlstrup, Niels
Vernon, Stephen T.
Engstrøm, Thomas
Lønborg, Jacob
Figtree, Gemma A.
Cardiovascular magnetic resonance characteristics and clinical outcomes of patients with ST-elevation myocardial infarction and no standard modifiable risk factors–A DANAMI-3 substudy
title Cardiovascular magnetic resonance characteristics and clinical outcomes of patients with ST-elevation myocardial infarction and no standard modifiable risk factors–A DANAMI-3 substudy
title_full Cardiovascular magnetic resonance characteristics and clinical outcomes of patients with ST-elevation myocardial infarction and no standard modifiable risk factors–A DANAMI-3 substudy
title_fullStr Cardiovascular magnetic resonance characteristics and clinical outcomes of patients with ST-elevation myocardial infarction and no standard modifiable risk factors–A DANAMI-3 substudy
title_full_unstemmed Cardiovascular magnetic resonance characteristics and clinical outcomes of patients with ST-elevation myocardial infarction and no standard modifiable risk factors–A DANAMI-3 substudy
title_short Cardiovascular magnetic resonance characteristics and clinical outcomes of patients with ST-elevation myocardial infarction and no standard modifiable risk factors–A DANAMI-3 substudy
title_sort cardiovascular magnetic resonance characteristics and clinical outcomes of patients with st-elevation myocardial infarction and no standard modifiable risk factors–a danami-3 substudy
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9383416/
https://www.ncbi.nlm.nih.gov/pubmed/35990971
http://dx.doi.org/10.3389/fcvm.2022.945815
work_keys_str_mv AT mazharjawad cardiovascularmagneticresonancecharacteristicsandclinicaloutcomesofpatientswithstelevationmyocardialinfarctionandnostandardmodifiableriskfactorsadanami3substudy
AT ekstromkathrine cardiovascularmagneticresonancecharacteristicsandclinicaloutcomesofpatientswithstelevationmyocardialinfarctionandnostandardmodifiableriskfactorsadanami3substudy
AT kozorrebecca cardiovascularmagneticresonancecharacteristicsandclinicaloutcomesofpatientswithstelevationmyocardialinfarctionandnostandardmodifiableriskfactorsadanami3substudy
AT grievestuartm cardiovascularmagneticresonancecharacteristicsandclinicaloutcomesofpatientswithstelevationmyocardialinfarctionandnostandardmodifiableriskfactorsadanami3substudy
AT nepperchristensenlars cardiovascularmagneticresonancecharacteristicsandclinicaloutcomesofpatientswithstelevationmyocardialinfarctionandnostandardmodifiableriskfactorsadanami3substudy
AT ahtarovskikirila cardiovascularmagneticresonancecharacteristicsandclinicaloutcomesofpatientswithstelevationmyocardialinfarctionandnostandardmodifiableriskfactorsadanami3substudy
AT kelbækhenning cardiovascularmagneticresonancecharacteristicsandclinicaloutcomesofpatientswithstelevationmyocardialinfarctionandnostandardmodifiableriskfactorsadanami3substudy
AT høfstendane cardiovascularmagneticresonancecharacteristicsandclinicaloutcomesofpatientswithstelevationmyocardialinfarctionandnostandardmodifiableriskfactorsadanami3substudy
AT køberlars cardiovascularmagneticresonancecharacteristicsandclinicaloutcomesofpatientswithstelevationmyocardialinfarctionandnostandardmodifiableriskfactorsadanami3substudy
AT vejlstrupniels cardiovascularmagneticresonancecharacteristicsandclinicaloutcomesofpatientswithstelevationmyocardialinfarctionandnostandardmodifiableriskfactorsadanami3substudy
AT vernonstephent cardiovascularmagneticresonancecharacteristicsandclinicaloutcomesofpatientswithstelevationmyocardialinfarctionandnostandardmodifiableriskfactorsadanami3substudy
AT engstrømthomas cardiovascularmagneticresonancecharacteristicsandclinicaloutcomesofpatientswithstelevationmyocardialinfarctionandnostandardmodifiableriskfactorsadanami3substudy
AT lønborgjacob cardiovascularmagneticresonancecharacteristicsandclinicaloutcomesofpatientswithstelevationmyocardialinfarctionandnostandardmodifiableriskfactorsadanami3substudy
AT figtreegemmaa cardiovascularmagneticresonancecharacteristicsandclinicaloutcomesofpatientswithstelevationmyocardialinfarctionandnostandardmodifiableriskfactorsadanami3substudy